Akari Therapeutics (AKTX) Depreciation & Amortization (CF) (2014 - 2024)
Akari Therapeutics recorded quarterly Depreciation & Amortization (CF) of $1000.0 in Q4 2024, down 92.31% quarter-over-quarter from $13000.0 in Q1 2024, and little changed year-over-year from $1000.0 in Q1 2024.
Akari Therapeutics' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $1000.0 for Q4 2024.
- In Q4 2024, Depreciation & Amortization (CF) changed 0.0% year-over-year to $1000.0; the TTM figure through Sep 2025 stood at $1000.0 (down 92.86% YoY), while the FY2024 annual figure was $14000.0, up 250.0% from the prior year.
- Depreciation & Amortization (CF) came in at $1000.0 for Q4 2024 at Akari Therapeutics, down from $13000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $13000.0 in Q1 2024 to a low of $986.0 in Q3 2020.
- A 3-year average of $2690.7 and a median of $1000.0 in 2020 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) tumbled 78.69% in 2020 and jumped 1200.0% in 2024, its largest moves.
- Akari Therapeutics' Depreciation & Amortization (CF) stood at $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1000.0, $13000.0, and $1000.0 for Q4 2024, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 2.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 986.00 |
| Sep 30, 2020 | 986.00 |
| Jun 30, 2020 | 3,044.00 |
| Jun 30, 2020 | 3,044.00 |
| Mar 31, 2020 | 3,877.00 |
| Mar 31, 2020 | 3,877.00 |
| Dec 31, 2019 | 4,313.00 |
| Dec 31, 2019 | 4,313.00 |
| Sep 30, 2019 | 4,626.00 |
| Sep 30, 2019 | 4,626.00 |
| Jun 30, 2019 | 4,700.00 |
| Jun 30, 2019 | 4,700.00 |
| Mar 31, 2019 | 5,566.00 |
| Mar 31, 2019 | 5,566.00 |
| Dec 31, 2016 | 8,436.00 |
| Dec 31, 2016 | 8,436.00 |
| Sep 30, 2016 | 9,677.00 |
| Sep 30, 2016 | 9,677.00 |
| Jun 30, 2016 | 10,191.00 |
| Jun 30, 2016 | 10,191.00 |
| Mar 31, 2016 | 8,594.00 |
| Mar 31, 2016 | 8,594.00 |
| Dec 31, 2015 | 2,616.00 |
| Dec 31, 2015 | 2,616.00 |
| Sep 30, 2015 | 2,793.00 |
| Sep 30, 2015 | 2,793.00 |
| Jun 30, 2015 | 867.00 |
| Jun 30, 2015 | 867.00 |
| Mar 31, 2015 | 764.00 |
| Mar 31, 2015 | 764.00 |
| Dec 31, 2014 | 1,596.00 |
| Dec 31, 2014 | 1,596.00 |
| Sep 30, 2014 | 1,455.00 |
| Sep 30, 2014 | 1,455.00 |